Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products... Show more
AYTU is expected to report earnings to rise 100.00% to -10 cents per share on November 12
Q3'26
Est.
$-0.10
Q2'26
Beat
by $0.17
Q1'26
Missed
by $0.32
Q2'25
Missed
by $3.46
Q1'23
Missed
by $1.30
The last earnings report on September 22 showed earnings per share of -5 cents, beating the estimate of -21 cents. With 8.42K shares outstanding, the current market capitalization sits at 21.52M.